Cell Cycle Effects of Iniparib, a PARP Inhibitor, in Combination with Gemcitabine and Carboplatin in the MDA-MB-468(-) Triple-Negative Breast Cancer (TNBC) Cell Line

被引：0
|
作者：
Ossovskaya, V.
Lim, C-U
Schools, G.
Kalurupalle, S.
Roninson, I. B.
Broude, E.
机构：
[1] BiPar Sci Inc, San Francisco, CA USA
[2] Ctr Canc, Ordway Res Inst, Albany, NY USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1156/0006-5472.SABCS10-P5-06-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-06-09
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The chemosensitizing properties of iniparib in combination with DNA-damaging agents in the MDA-MB-468(-) triple-negative breast cancer (TNBC) cell line
    Ossovskaya, Valeria
    Lim, Chang-Uk
    Schools, Gary
    Kalurupalle, Swathi
    Roninson, Igor B.
    Broude, Eugenia
    CANCER RESEARCH, 2011, 71
  • [2] Characterization of functional heterogeneity and in vivo dynamics of clonal cell populations derived from the triple-negative breast cancer cell line MDA-MB-468
    Kuiken, Hendrik J.
    Dhakal, Sabin
    Selfors, Laura M.
    Crowdis, Jett P.
    Bhang, Hyo-eun C.
    Stegmeier, Frank
    Mills, Gordon B.
    Brugge, Joan S.
    CANCER RESEARCH, 2017, 77
  • [3] Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line
    Hajizadeh, Masoumeh
    Ghoran, Salar Hafez
    Azeez, Hewa Jalal
    Feizi, Mohammad Ali Hosseinpour
    Babaei, Esmaeil
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (11) : 2181 - 2188
  • [4] Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles
    Wojtowicz, Wojciech
    Wrobel, Anna
    Pyziak, Karolina
    Tarkowski, Radoslaw
    Balcerzak, Alicja
    Bebenek, Marek
    Mlynarz, Piotr
    METABOLITES, 2020, 10 (05)
  • [5] SAR optimization studies on a novel series of 2-anilinopyrimidines as selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
    Jo, Jeyun
    Kim, Heegyu
    Oh, Ji Youn
    Kim, Soyeong
    Park, Yeong Hye
    Choi, Hyeonjin
    Jeong, Jee-Yeong
    Jung, Young-Suk
    Yun, Hwayoung
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (24)
  • [6] Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
    Jo, Jeyun
    Kim, Sou Hyun
    Kim, Heegyu
    Jeong, Myeonggyo
    Kwak, Jae-Hwan
    Han, Young Taek
    Jeong, Jee-Yeong
    Jung, Young-Suk
    Yun, Hwayoung
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (01) : 62 - 65
  • [7] β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells
    Di Sotto, Antonella
    Gulli, Marco
    Minacori, Marco
    Mancinelli, Romina
    Garzoli, Stefania
    Percaccio, Ester
    Incocciati, Alessio
    Romaniello, Donatella
    Mazzanti, Gabriela
    Eufemi, Margherita
    Di Giacomo, Silvia
    BIOMEDICINES, 2022, 10 (09)
  • [8] Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
    Alsrhani, Abdullah
    Elderdery, Abozer Y.
    Alzahrani, Badr
    Alzerwi, Nasser A. N.
    Althobiti, Maryam Musleh
    Rayzah, Musaed
    Idrees, Bandar
    Elkhalifa, Ahmed M. E.
    Subbiah, Suresh K.
    Mok, Pooi Ling
    MOLECULES, 2023, 28 (07):
  • [9] Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib
    Wang, Xinzhao
    Song, Hongkuan
    Yu, Qian
    Liu, Qi
    Wang, Leilei
    Liu, Zhaoyun
    Yu, Zhiyong
    ONCOLOGY REPORTS, 2015, 33 (02) : 526 - 532
  • [10] Sericin inhibits MDA-MB-468 cell proliferation via the PI3K/Akt pathway in triple-negative breast cancer
    Niu, Lin
    Yang, Songhe
    Zhao, Xueying
    Liu, Xiaochao
    Si, Lina
    Wei, Meng
    Liu, Lei
    Cheng, Luyang
    Qiao, Yuebing
    Chen, Zhihong
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)
12345